首页> 外文期刊>Yonsei Medical Journal >Increased Inflammation, Reduced Plasma Phospholipid Eicosapentaenoic Acid and Reduced Antioxidant Potential of Treated Hypertensive Patients with Metabolic Syndrome
【24h】

Increased Inflammation, Reduced Plasma Phospholipid Eicosapentaenoic Acid and Reduced Antioxidant Potential of Treated Hypertensive Patients with Metabolic Syndrome

机译:高血压综合征代谢综合征患者的炎症增加,血浆磷脂二十碳五烯酸减少和抗氧化潜能降低

获取原文
           

摘要

Purpose In the present study, we tested whether the presence of metabolic syndrome (MetS) would worsen the features of inflammation, plasma omega 3 fatty acid levels and antioxidant potential in treated hypertensive patients. Materials and Methods Two groups were classified by the components of MetS: a reference group of treated hypertensive subjects: hypertension (HTN) group (n = 39) and with more than two additional MetS components: HTN with Mets group (n = 40). We further compared the parameters between HTN group and HTN with MetS group. Results The results showed that age ( p Conclusion In conclusion, our results showed increased inflammatory marker, reduced antioxidant potential and EPA levels in treated hypertensive patients in the presence of MetS, suggesting the importance of changes of therapeutic lifestyle to modify the features of MetS.
机译:目的在本研究中,我们测试了代谢综合征(MetS)的存在是否会加重高血压患者的炎症,血浆omega 3脂肪酸水平和抗氧化能力。材料和方法根据MetS的成分将两组分为:治疗组的参考对象:高血压(HTN)组(n = 39)和另外两个以上的MetS成分:具有Mets的HTN组(n = 40)。我们进一步比较了HTN组和带有MetS组的HTN之间的参数。结果结果表明,年龄(p结论)总之,我们的结果显示,在存在MetS的情况下,治疗的高血压患者的炎症标志物增加,抗氧化剂潜力和EPA水平降低,表明改变治疗生活方式以改变MetS特征的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号